ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14. The firm has a market capitalization of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. The firm’s 50-day moving average price is $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.